Oncology

Microbial particles may boost the effectiveness of immunotherapy in stomach cancer

Bacterial extracellular vesicles released by L. salivarius activate immune cells, boosting the effectiveness of immunotherapy in stomach cancer.

Dietary fiber and gastric cancer: pooled international data support a dose-dependent protective effect

Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.

Postbiotics as a new frontier in healthcare: from gut barrier function to cancer immunotherapy

Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.

Healthy donor fecal transplants may boost immunotherapy in kidney cancer

Modifying the microbiota through a fecal transplant can be safely combined with immunotherapy in people with kidney cancer.

Gut bacterial genes may control how diet influences tumor growth and immunity

Gut microbes can influence cancer outcomes by regulating nutrient availability and uptake in immune cells.

Simple rectal mucus test shows promise for detecting colon cancer 

Researchers identified 36 bacterial species, particularly Hungatella hathewayi and Intestinimonas butyriciproducens, associated with colorectal cancer.

Some oral microbes may influence esophageal cancer risk

Certain harmful microbes in the mouth appear to promote cancer development, while others might help protect against it. 

Microbial metabolites may help immune cells fight melanoma 

Diet and gut microbes can shape immune cell function and improve responses to anti-cancer therapy.

Fecal profiling of pancreatic cancer

Results of a recent study showed reduced microbial diversity and distinct microbial profile in the two groups of PC patients.

Gut bacteria may help predict lung cancer treatment success

Changes in gut bacteria, especially Akkermansia, could predict treatment success in people with lung cancer.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.